CTRI/2021/07/034509已完成未知
Prospective, international, multicenter, observational study to evaluate theclinical performance and safety of a DACC-impregnatedtransparent postoperative dressing
Essity India Private Limited0 个研究点目标入组 112 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 112
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Signed informed consent to participate in this study
- •2.Men, women or diverse
- •3.ââ?°Â¥ 18 years of age
- •4.Patient is mentally and physically able to participate in this study
- •5.Wound from gastrointestinal or orthopaedical surgeries indicated for treatment with the investigational products for a time period of 14 days
排除标准
- •1.Infection of the target wound
- •2.Patients actively taking antibiotics for other conditions up to the day of surgery (not including surgical prophylaxis or antibiotic use related to the index procedure)
- •3.Subjects require placement of external fixators
- •4.Any drug addiction including alcohol
- •5.Known sensitivity or allergy to any component of the study product
- •6.Patients who participate in any other clinical study investigating drugs or medical devices
- •7.Patients not willing to attend at follow-up visits
- •8.Patients not able to give consent
- •9.Pregnant or breastfeeding patients
研究者
相似试验
已完成
1 期
A multicentre, multinational prospective observational imaging biomarker study in early stage Huntington?s disease (HD) patients to assess imaging techniques and parameters able to support efficacy studies with SEN0014196 in HD patients during Phase II and III studiesISRCTN26193242Siena Biotech (Italy)60
进行中（未招募）
不适用
Ensayo multicéntrico, internacional, prospectivo, aleatorizado, doble ciego y con doble simulación que compara la seguridad y eficacia de la administración secuencial (intravenosa/ oral) de moxifloxacino 400 mg una vez al día con la administración de piperacilina/tazobactam 4,0/0,5 g por vía intravenosa cada 8 horas seguida de amoxicilina/ácido clavulánico comprimidos 875/125 mg por vía oral cada 12 horas para el tratamiento de pacientes con infecciones complicadas de la piel y los tejidos blandos (Estudio RELIEF) - RELIEFEUCTR2006-001599-18-ESBayer HealthCare AG804
尚未招募
不适用
Observational study of Insulin Glargine 300 u/ml performed before, during and after period of Ramadan, in patients with Type 2 Diabetes MellitusCTRI/2019/02/017636Sanofi India Limited
已完成
不适用
CONVINCE An international, multi-centre, prospective, randomised, controlled study comparing high-dose Haemodiafiltration (HDF) versus conventional high-flux Haemodialysis (HD).End Stage Kidney Disease10038430renal insufficiencyNL-OMON52958niversitair Medisch Centrum Utrecht100
尚未招募
4 期
A study to find out if Toujeo is safe and efficient in patients with Ty 2 DM, who previously were taking another basal insulin but wasnt efficient. A basal insulin is secreted continuously during the day into the bloodstream from SC depot, when a natural secretion from pancreas is reduced.CTRI/2019/08/020701SanofiAventis Groupe